Tivozanib in renal cell carcinoma: a new approach to previously treated disease

Tivozanib in renal cell carcinoma: a new approach to previously treated disease

Targeted therapies have been a mainstay of the renal cell carcinoma (RCC) treatment paradigm for the better part of two decades. Multikinase inhibitors of the vascular endothelial growth factor receptor tyrosine kinases (VEGF-TKIs) comprise nearly all targeted therapies in RCC, having been prospecti...

Full description

Bibliographic Details
Main Authors:	Nicholas J. Salgia, Zeynep B. Zengin, Sumanta K. Pal
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-05-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/1758835920923818

Similar Items

Tivozanib in the treatment of renal cell carcinoma
by: Hepgur M, et al.
Published: (2013-06-01)

Tivozanib for the treatment of renal cell carcinoma: patient selection and perspectives
by: Rodenburg RJ, et al.
Published: (2019-05-01)

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma
by: Cowey CL
Published: (2013-06-01)

Impact of tivozanib on patient outcomes in treatment of advanced renal cell carcinoma
by: Yalcin S, et al.
Published: (2019-08-01)

Tivozanib in renal cell carcinoma: a systematic review of the evidence and its dissemination in the scientific literature
by: Caquelin, L., et al.
Published: (2022)

Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
by: Jacob J. Adashek, et al.
Published: (2018-05-01)

Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices
by: Nicholas J. Salgia, et al.
Published: (2020-05-01)

Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy era.
by: Sumanta K Pal, et al.
Published: (2013-01-01)

Renal cell carcinoma: An update for the practicing urologist
by: Sumanta K. Pal, et al.
Published: (2015-01-01)

Radiation induced esophageal adenocarcinoma in a woman previously treated for breast cancer and renal cell carcinoma
by: Raissouni Soundouss, et al.
Published: (2012-08-01)

Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors
by: Sumanta Kumar Pal, et al.
Published: (2010-01-01)

Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients
by: Suresh Gopi Kalathil, et al.
Published: (2020-01-01)

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
by: Matteo Santoni, et al.
Published: (2019-12-01)

Metastasis in renal cell carcinoma: Biology and implications for therapy
by: Jun Gong, et al.
Published: (2016-10-01)

Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide‐based vaccine
by: Ryoma Kurahashi, et al.
Published: (2020-03-01)

nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma
by: Go Makimoto, et al.
Published: (2014-01-01)

Hydronephrotic Kidney Previously Treated for Tuberculosis: Rare Primary Squamous Cell Carcinoma of Renal Pelvis Diagnosed by Fine-needle Aspiration Cytology
by: Dragica Obad-Kovačević, et al.
Published: (2015-09-01)

Spotlight on cabozantinib for previously untreated advanced renal cell carcinoma: evidence to date
by: Bersanelli M, et al.
Published: (2018-09-01)

Endobronchial Metastasis of Renal Carcinoma: A Case Report and Review of Previous Literature
by: Guang-Lei Zhang, et al.
Published: (2021-05-01)

Clinicopathological characteristics of surgically treated localized renal masses in patients previously exposed to chemotherapy
by: Efrat Tsivian, et al.

Small cell carcinoma of the lung in a patient with previously treated synchronous adenocarcinoma and squamous cell carcinoma
by: Asad Ullah, et al.
Published: (2021-01-01)

Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma
by: Marcin Kortylewski, et al.
Published: (2021-03-01)

Everolimus in patients with metastatic renal cell carcinoma previously treated with bevacizumab: a prospective multicenter study CRAD001LRU02T⃰
by: I. Tsimafeyeu, et al.
Published: (2015-06-01)

Axitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation
by: Steve J Edwards, et al.
Published: (2018-01-01)

Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam Therapy
by: Hiroaki Takahashi, et al.
Published: (2019-01-01)

Laryngeal recurrence sites in patients previously treated with transoral laser microsurgery for squamous cell carcinoma
by: P. Horwich, et al.
Published: (2018-02-01)

645 Preclinical development of a novel colon-targeted therapeutic for the treatment of immune checkpoint inhibitor (ICI)-colitis
by: Sumanta Pal, et al.
Published: (2020-11-01)

Venetoclax in Previously Treated Waldenström Macroglobulinemia
by: Advani, R.H, et al.
Published: (2022)

Concurrent Multilocular Cystic Renal Cell Carcinoma and Leiomyoma in the Same Kidney: Previously Unreported Association
by: Min Su Cheong, et al.
Published: (2010-07-01)

Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma
by: Karakiewicz PI, et al.
Published: (2016-05-01)

A case of metastatic renal cell carcinoma with concomitant Castleman's disease treated with immunotherapy
by: Taja Lozar, et al.
Published: (2021-09-01)

Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial
by: Jianhui Ma, et al.
Published: (2020-05-01)

Risk Factors for De Novo Squamous Cell Carcinoma Development in Renal Transplant Recipients with a Previous Squamous Cell Carcinoma
by: Vivan C. Hellström, et al.
Published: (2017-03-01)

Differentiating Induced Pluripotent Stem Cells into Renal Cells: A New Approach to Treat Kidney Diseases
by: Patrícia de Carvalho Ribeiro, et al.
Published: (2020-01-01)

Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data
by: Cohen Herbert T, et al.
Published: (2003-11-01)

Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma
by: Yusuke Okuma, et al.
Published: (2020-10-01)

Paclitaxel with Cisplatin as Salvage Treatment for Patients with Previously Treated Advanced Transitional Cell Carcinoma of the Urothelial Tract
by: Ji Eun Uhm, et al.
Published: (2007-01-01)

Managing adults with previously treated anorectal malformations
by: Alemayehu Ginbo Bedada, et al.
Published: (2019-01-01)

A New Heuristic Approach for Treating Missing Value: ABCimp
by: Pinar Cihan, et al.
Published: (2019-12-01)

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program
by: Elena Verzoni, et al.
Published: (2019-04-01)